Avondale Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-44
| Closed | -$23.4K | – | 129 |
|
|
2023
Q4 | $23.4K | Hold |
44
| – | – | 0.02% | 101 |
|
|
2023
Q3 | $22.3K | Hold |
44
| – | – | 0.02% | 103 |
|
|
2023
Q2 | $23K | Hold |
44
| – | – | 0.02% | 100 |
|
|
2023
Q1 | $25.4K | Hold |
44
| – | – | 0.02% | 101 |
|
|
2022
Q4 | $24.2K | Hold |
44
| – | – | 0.02% | 92 |
|
|
2022
Q3 | $22K | Hold |
44
| – | – | 0.02% | 93 |
|
|
2022
Q2 | $24K | Sell |
44
-46
| -51% | -$25.1K | 0.03% | 84 |
|
|
2022
Q1 | $53K | Hold |
90
| – | – | 0.06% | 64 |
|
|
2021
Q4 | $60K | Sell |
90
-27
| -23% | -$18K | 0.06% | 62 |
|
|
2021
Q3 | $67K | Hold |
117
| – | – | 0.07% | 65 |
|
|
2021
Q2 | $59K | Hold |
117
| – | – | 0.06% | 68 |
|
|
2021
Q1 | $53K | Hold |
117
| – | – | 0.05% | 66 |
|
|
2020
Q4 | $54K | Hold |
117
| – | – | 0.06% | 52 |
|
|
2020
Q3 | $52K | Hold |
117
| – | – | 0.08% | 38 |
|
|
2020
Q2 | $42K | Hold |
117
| – | – | 0.06% | 44 |
|
|
2020
Q1 | $33K | Hold |
117
| – | – | 0.05% | 51 |
|
|
2019
Q4 | $38K | Hold |
117
| – | – | 0.06% | 52 |
|
|
2019
Q3 | $34K | Hold |
117
| – | – | 0.06% | 54 |
|
|
2019
Q2 | $34K | Hold |
117
| – | – | 0.03% | 58 |
|
|
2019
Q1 | $32K | Hold |
117
| – | – | 0.02% | 60 |
|
|
2018
Q4 | $26K | Hold |
117
| – | – | 0.02% | 67 |
|
|
2018
Q3 | $29K | Hold |
117
| – | – | 0.03% | 57 |
|
|
2018
Q2 | $24K | Hold |
117
| – | – | 0.02% | 58 |
|
|
2018
Q1 | $24K | Hold |
117
| – | – | 0.02% | 59 |
|
|
2017
Q4 | $22K | Buy |
+117
| New | +$22K | 0.02% | 67 |
|